Synthetic mRNA-based gene therapy for glioblastoma: TRAIL-mRNA synergistically enhances PTEN-mRNA-based therapy
Glioblastoma (GBM) is characterized as having high molecular heterogeneity and complexity, which can be well revealed by genomic study. A truly effective treatment for GBM should flexibly address its heterogeneities, complexity, and strong drug resistance. This study was performed to explore the eff...
Salvato in:
| Autori principali: | , , , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2022-03-01
|
| Serie: | Molecular Therapy: Oncolytics |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2372770522000171 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|